American Psychiatric Association: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk mNo edit summary |
imported>Robert Badgett No edit summary |
||
| Line 4: | Line 4: | ||
The '''American Psychiatric Association''' (APA) is a professional society for physicians who specialize in the treatment of mental disorders. The APA has more than 35,000 members, all of whom are qualified, or in the process of becoming qualified, as [[psychiatrist|psychiatrists]]. | The '''American Psychiatric Association''' (APA) is a professional society for physicians who specialize in the treatment of mental disorders. The APA has more than 35,000 members, all of whom are qualified, or in the process of becoming qualified, as [[psychiatrist|psychiatrists]]. | ||
==Controversy== | |||
The American Psychiatric Association is reported to have 30% of its financing through the pharmaceutical industry which may create a [[conflict of interest]].<ref name="urlPsychiatric Group Faces Scrutiny Over Drug Industry Ties - NYTimes.com">{{cite web |url=http://www.nytimes.com/2008/07/12/washington/12psych.html |title=Psychiatric Group Faces Scrutiny Over Drug Industry Ties|author=Benedict Carey, Gardiner Harris |authorlink= |coauthors= |date=July 12, 2008 |format= |work= |publisher=New York Times |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | |||
Latest revision as of 09:23, 14 July 2008
- The American Psychological Association is a similarly named society for psychologists.
The American Psychiatric Association (APA) is a professional society for physicians who specialize in the treatment of mental disorders. The APA has more than 35,000 members, all of whom are qualified, or in the process of becoming qualified, as psychiatrists.
Controversy
The American Psychiatric Association is reported to have 30% of its financing through the pharmaceutical industry which may create a conflict of interest.[1]
- ↑ Benedict Carey, Gardiner Harris (July 12, 2008). Psychiatric Group Faces Scrutiny Over Drug Industry Ties. New York Times.